3P innovation

Activities: Digital Pharmaceutical

Trending Articles

  1. Chrysalis expands scalable modular rental cleanrooms for Boston biotechs The cleanroom hosting provider has redesigned its GMP facility to offer four isolated ISO Class 7 and ISO Class 8 suites for Boston biotech companies
  2. DuPont launches sustainable cleanroom PPE following LCA assessment The chemical and materials science company has introduced a new disposable garment that delivers chemical, biological and antistatic protection for cleanrooms while reducing...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Annex 1 and “first air”: What is it and how is it used? First Air as a concept is a major update in the new Annex 1 to continue global harmonisation of regulatory standards, but what is it and how is it used in the new document to...
  4. Samsung speeds up construction of P5 cleanroom for HBM production Samsung Electronics has accelerated the construction of its Pyeongtaek P5 semiconductor fab for high-bandwidth memory production by reinforcing its pre-emptive “Shell...
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    2025: What happened in the cleanroom market? Sophie Bullimore looks back at what was happening in the cleanroom sector in 2025, and what trends jumped out amongst the rest

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

Related Content

You need to be a subscriber to read this article.
Click here to find out more.
Pharmaceutical

Designing contamination control into pharmaceutical equipment

Contamination Control Strategies (CCS) demand a holistic approach to personnel, process design, equipment, and environmental controls. Dr Dave Seaward, from 3P Innovation dives into equipment design aspects that make the difference to the entire system

The future of cleanrooms: automation, digitisation and sustainability

19 February 2026 | Virtual
Pharmaceutical

Filling syringes with spray-dried powders - the how, the why and the benefits

For many therapy developers, the challenge doesn’t start in manufacturing, it begins much earlier in formulation
You need to be a subscriber to read this article.
Click here to find out more.
Design & Build

What is the future of automation in closed systems for cell and gene therapy production?

Dave Seaward from 3P Innovation explains why manufacturers in advanced therapies are moving away from manual, laboratory-based processes and toward automated operations on GMP-compliant production equipment
Pharmaceutical

The basics of cell culture: key steps in manufacturing cell therapies

Cell therapies represent a promising frontier in medicine, offering potential treatments and cures for a wide range of diseases. However, before these therapies can reach patients, they must undergo a complex manufacturing process. Central to this process is cell culture, a crucial step in producing the therapeutic cells needed for treatment. In this blog, we'll delve into the fundamentals of cell culture, outlining the key steps involved in manufacturing cell therapies
Digital

Shaping the future of ATMPs: tailored automation and advanced technologies for the next decade

If history is to repeat itself, the next 10 years will see significant activity regarding the automation of advanced therapy medicinal products (ATMPs). Having said that, however, one size is unlikely to fit all. Several core solutions tuned to specific therapies are likely to appear. By Dr Dave Seaward
Pharmaceutical

Responding to cell & gene fill-finish and automation scale-up challenges

Before delving into some technical details of cell and gene therapy manufacturing, it’s worth pausing to reflect on the human stories that drive this innovation. These therapies are not just scientific marvels - they're changing lives
Subscribe now